These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 31778548)

  • 1. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
    Suzuki-Inoue K; Osada M; Ozaki Y
    J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model.
    Shirai T; Tsukiji N; Sasaki T; Oishi S; Yokomori R; Takano K; Suzuki-Inoue K
    J Thromb Haemost; 2023 Nov; 21(11):3153-3165. PubMed ID: 37473844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.
    Tsukiji N; Osada M; Sasaki T; Shirai T; Satoh K; Inoue O; Umetani N; Mochizuki C; Saito T; Kojima S; Shinmori H; Ozaki Y; Suzuki-Inoue K
    Blood Adv; 2018 Sep; 2(17):2214-2225. PubMed ID: 30190281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
    Suzuki-Inoue K
    J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.
    Inoue O; Hokamura K; Shirai T; Osada M; Tsukiji N; Hatakeyama K; Umemura K; Asada Y; Suzuki-Inoue K; Ozaki Y
    PLoS One; 2015; 10(9):e0139357. PubMed ID: 26418160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
    Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
    J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
    Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
    J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.
    Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y
    J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the CLEC-2-podoplanin interaction in tumor progression.
    Suzuki-Inoue K
    Platelets; 2018 Jun; ():1-7. PubMed ID: 29863945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet CLEC-2 and podoplanin in cancer metastasis.
    Lowe KL; Navarro-Nunez L; Watson SP
    Thromb Res; 2012 Apr; 129 Suppl 1():S30-7. PubMed ID: 22682130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiological and pathophysiological roles of platelet CLEC-2.
    Navarro-Núñez L; Langan SA; Nash GB; Watson SP
    Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
    Yokomori R; Shirai T; Tsukiji N; Oishi S; Sasaki T; Takano K; Suzuki-Inoue K
    Platelets; 2023 Dec; 34(1):2281941. PubMed ID: 38010137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
    Suzuki Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.
    Payne H; Ponomaryov T; Watson SP; Brill A
    Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
    Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction.
    Tsukiji N; Inoue O; Morimoto M; Tatsumi N; Nagatomo H; Ueta K; Shirai T; Sasaki T; Otake S; Tamura S; Tachibana T; Okabe M; Hirashima M; Ozaki Y; Suzuki-Inoue K
    Blood; 2018 Sep; 132(11):1167-1179. PubMed ID: 29853539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.